Komal Jhaveri, MD, Memorial Sloan Kettering Cancer Center and lead author of the EMBER-3 trial, as she discusses the significance of this approval, its impact on the treatment…
Sung-Bae Kim, MD, PhD, Asan Medical Center, Seoul, South Korea, reports on results from the East Asian subgroup of the Phase 3 EMBER‑3 trial, showing that in patients…
John Lehr, CEO of the Parkinson’s Foundation, shares insights into how advances in research, education, and advocacy for patients with Parkinson’s (and the disease itself) is performed and…
Perfusion decellularization has recently been used to remove genetic material in pig organs, allowing them to be seeded with human stem cells in the hopes of securing a…
Over the last two and a half years, Stanford University researchers have been developing and improving a brain-computer interface (BCI) that allows paralyzed individuals to input data into…
The trial revealed a linear correlation between higher tumor burden and anti-PD1 and anti-programmed death ligand (PD-L1) checkpoint inhibitors, explained as the immune system responding to reactivation.
For some patients, nutritional supplements can play a role in boosting the immune system and priming the body to better react to certain pathogens. Olive leaf extract has…
